ProBioGen AG, a leading biotechnology company in mammalian cell engineering and cell culture, today announced the appointment of Dr Gertraud Unterrainer to Chief Financial Officer. Dr Unterrainer will complement and strengthen ProBioGen´s current management team consisting of Michael Schlenk, CEO, and Dr Uwe Marx, CSO.
